tirzepatide surmount 3 for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Psychiatric Safety of Tirzepatide: 3

Long-term trials like LEADER confirmed cardiovascular and renal safety for liraglutide in T2D, with no increased risk of pancreatitis or thyroid malignancy [34]

Severe side effects and warnings of GLP-1s Serious side effects with GLP-1 medications are rare, but knowing what to watch for can help you catch problems early

Our team works closely with businesses to resolve any import compliance issues related to FDA-regulated goods

Weight loss drug semaglutide linked to better heart health 14 May 2024 The weight loss drug semaglutide delivers cardiovascular benefits irrespective of starting weight and amount of weight lost, according to preliminary findings from a UCL-led research team

Laziness or lack of attention-to-detail or GTM rush?Given the semaglutide gold rush is projected to be a billion$ therapy area in upcoming months, they could have well avoided this fiasco